Orsero (ORS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
3 Feb, 2026Executive summary
H1 2025 delivered strong growth, with net sales up 13.6% year-over-year to €845.2 million and profit for the period rising to €19.7 million, driven by robust Distribution BU performance across all geographies, especially Italy and the Iberian Peninsula, with France showing resilience.
Adjusted EBITDA rose 18.4% to €48.4 million, with margin improving to 5.7% from 5.5% in H1 2024.
Adjusted net profit grew 30.9% to €20.9 million; reported net profit was €19.7 million, up 30.8%.
The Group maintained robust business performance and continued strategic investments and dividend payouts despite a complex macroeconomic and geopolitical environment.
Financial highlights
Net sales: €845.2 million (up from €744.1 million in H1 2024); Distribution BU contributed €804.3 million (+13.7%), Shipping BU €60.0 million (+3.5%).
Adjusted EBITDA: €48.4 million (up from €40.9 million), margin improved to 5.7%.
Adjusted EBIT: €30.5 million (up from €24.2 million).
Net financial position at €111.3 million, including IFRS 16 effect.
Cash flow from operating activities increased to €34.0 million (vs €23.6 million in H1 2024).
Outlook and guidance
FY 2025 guidance revised upwards: net sales expected between €1,650–1,690 million, adjusted EBITDA €82–86 million, adjusted net profit €30–32 million, and investments in operating fixed assets €19–21 million.
Net financial position guidance unchanged at €110–105 million.
H2 expected to be less strong than H1, reflecting a very strong Q3 2024 comparison and prudent forecasting.
ESG targets for 2025 include full employee sustainability training and 100% food safety certification for warehouses.
Management remains confident in medium- to long-term growth potential, supported by strong competitive positioning and financial structure.
Latest events from Orsero
- FY 2025 exceeded guidance with strong growth, margins, and a proposed €0.61 dividend.ORS
Q4 202513 Mar 2026 - Net sales and EBITDA declined, but Q2 Distribution outperformed and cash flow stayed robust.ORS
H1 202420 Jan 2026 - Stable revenues and strong distribution offset profit decline; FY 2024 guidance confirmed.ORS
Q3 202413 Jan 2026 - 2024 targets met with resilient high-value growth and strong cash flow, despite margin pressure.ORS
Q4 202426 Dec 2025 - Q1 2025 net sales up 12.6%, EBITDA up 28%, guidance and dividend confirmed.ORS
Q1 202526 Nov 2025 - Strong revenue and profit growth in 9M 2025, with guidance confirmed at the upper end.ORS
Q3 202514 Nov 2025